Several different factors are involved in BC pathogenesis while its exact etiology is complicated and not clearly identified. Our recent publications have provided evidence that genetic factors play important roles in the pathogenesis and progressions of BC in the population of southeast of Iran (6) (7) (8) (9) (10) .
Somatic mutations in the genome are critical for transformation of normal cells into cancers. The existence of hundreds to thousands of mutations has been shown in most cancers (11) (12) (13) (14) .
APOBEC3s (A3s) gene cluster is located on chromosome 22q13.1-q13.2 including APOBEC3A,
APOBEC3B, APOBEC3C, APOBEC3D, APOBE-C3E, APOBEC3F, APOBEC3G, and APOBEC3H
which are arranged in tandem and play key roles in intracellular defense against viral infection (15, 16) . They all have the cytidine deaminase activity and are able to convert cytosine to uracil (15) .
Through copy number variation (CNV)
genome wide association study (GWAS), Long et al. realized a common (CNV) locus for breast cancer in Chinese women, which was located between the fifth exon of APOBEC3A and the eighth exon of APOBEC3B (17) . The finding was also repeated among women of European ancestry (18) . It has been shown that a 29.5 Kb deletion occurs between the fifth exon of APOBEC3A and the eighth exon of APOBEC3B, leading to the complete removal of the APOBEC3B coding region. Several studies have found an association between APOBEC3 deletion and risk of various cancers (17) (18) (19) .
To the best of our knowledge there is no any report regarding the association between APOBEC3 deletion and BC in Iranian women, therefore in the present study we aimed to find out the impact of APOBEC3 deletion on BC risk in a sample of Iranian population. 
Material and methods

Patients
Statistical analysis
All statistical analyzes were computed using statistical package SPSS 20 software. The differences between the variables were evaluated by chi-square test or independent sample t-test according to the data. The association between genotypes and BC were assessed by computing the odds ratio (OR) and 95% confidence intervals (95% CI) from logistic regression analyses. A p-value < 0.05 was considered as statistically significant.
According to our results, sample power was computed for APOBEC3 deletion by comparison of each genotype with the sum of other genotypes by using STATA 10 software (Table 1) . 
Discussion
In the current study we examined the impact of APOBEC3 deletion on BC risk in a sample of
Iranian population who were living in southeast of this country. The findings revealed that APOBEC3 deletion significantly increased the risk of breast catalyzes genomic DNA deamination and it is a main mutational source in BC accounting for C-to-T transitions (25) . Upregulation of APOBEC3B has been revealed in BC showing that it as an important source of enzymatic mutation and DNA damage that could inactivate the tumor suppressor TP53 gene (25) .
We found no significant association between APOBEC3 deletion and clinicopathological parameters of BC patients. To the best of our knowledge, there is no data regarding the impact of APOBEC3 deletion on response to treatment as well as prognosis of BC patients.
In conclusion, our findings indicated that APOBEC3 deletion significantly increased the risk of BC in an Iranian population in southeast of Iran.
Large sample sizes in diverse ethnicities are still required to certify our finding.
